Agenda
Thursday, November 9th, 2017
6:45 - 7:30 AM
Breakout Check-in & Networking Breakfast
7:30 - 8:15 AM
Breakout Sessions
OD/MD Collaboration & Competition (Signup Closed)
Focusing on the relationship between the MD and OD and how it impacts innovation
Co-moderator: Daniel Durrie, MD, President - Durrie Vision
Co-moderator: Eric Donnenfeld, MD, Clinical Professor of Ophthalmology – NYU/ Ophthalmic Consultants of Long Island
Joe Boorady, OD, President & CEO – TearScience, Johnson & Johnson Vision
James Thimons, OD, Clinical Director - Ophthalmic Consultants of Connecticut
MIGS/Glaucoma (Signup Closed)
Exploring the background and current state of MIGs: Successes, problems and future
Moderator: Richard Lewis, MD, Co-Founder - Sacramento Eye Consultants/Chief Medical Officer - Aerie Pharmaceuticals
Ron Bache, President & CEO - Bache, Inc.
Chris Calcaterra, Chief Commercial Officer – Glaukos Corporation
Ram Palanki, PharmD, SVP of Commercial, Americas - Santen
Private Equity & Private Practice (Signup Closed)
The role of private equity and consolidation in the future of ophthalmic care
Moderator: Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
Bruce Maller, President & CEO - BSM Consulting
Sami Abbasi, CEO - Unifeye Vision Partners
Mark Rosenberg, MD, Vice Chairman Board of Directors - American Vision Partners
A Discussion with Dr. Malvina Eydelman (Signup Closed)
Moderator: Kuldev Singh, MD, Professor of Ophthalmology - Stanford University
Nicholas Tarantino, OD, Chief Clinical & Regulatory Officer, Head R&D - AcuFocus
Malvina Eydelman, MD, Director, Division of Ophthalmic and Ear, Nose & Throat Devices – FDA
A Discussion with Dr. Wiley Chambers (Signup Closed)
Co-moderator: Gary Novack, PhD, President - PharmaLogic Development
Co-moderator: Peter Kaiser, MD, Professor of Ophthalmology - Cole Eye Institute
Wiley Chambers, MD, Deputy Director, Division of Transplant & Ophthalmology Products Center for Drug Evaluation & Research – FDA
Dry Eye - History and Current Activity (Signup Closed)
Moderator: Edward Holland, MD, Director, Cornea Services - Cincinnati Eye Institute
Kim Brazzell, PhD, Chief Medical Officer - Kala Pharmaceuticals
Susan Benton, Global New Products Lead & Global Product Strategy, Ophthalmics - Shire
John Sheppard, MD, Professor of Ophthalmology, Microbiology & Molecular Biology - Eastern Virginia Medical School
Retina Update – Interpreting and Looking Beyond the Highlights of 2017 (Signup Closed)
Moderator: Pravin Dugel, MD, Managing Partner - Retinal Consultants of Arizona
Jay Duker, MD, Founder - Hermera Biosciences
David S. Boyer, MD - Retina-Vitreous Associates Medical Group
Jeffrey Heier, MD, Co-President & Medical Director - Ophthalmic Consultants of Boston
7:45 - 8:30 AM
General Check-in & Networking Breakfast
Sponsored By:
8:30 - 8:40 AM
Welcome and Chairman’s 2017 Year in Review
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds
8:40 - 9:43 AM
Company Showcase 1
Co-Moderated By:
Jason Menzo, VP, Business Unit Head - Ophthalmics - Sun Pharmaceuticals
Samir Tari, MD, Senior Medical Director - Astellas
8:40 - 8:47 | AGTC | Sue Washer, President & CEO
8:47 - 8:54 | GenSight Biologics | Barrett Katz, MD, MBA, Chief Medical Officer
8:54 - 9:01 | Nightstar | David Fellows, CEO
9:01 - 9:08 | jCyte | David S. Boyer, MD, Investigator
9:08 - 9:15 | Bio-Tissue | Scheffer Tseng, MD, PhD, Medical Director & Chief Technology Officer
9:15 - 9:22 | Novaliq GmbH | Christian Roesky, CEO & Managing Director
9:22 - 9:29 | pSivida | Nancy Lurker, President & CEO
9:29 - 9:36 | EyeGate Pharmaceuticals | Stephen From, CEO
9:36 - 9:43 | Aciont | John Higuchi, CEO
9:43 - 10:39 AM
Company Showcase 2
Co-Moderated By:
Costin Curatu, Head, Search and Evaluation - Surgical , Business Development & Licensing - Alcon
Tracy Valorie, SVP & General Manager - Bausch + Lomb
9:43 - 9:50 | AcuFocus | Yari Mitchell, VP, Medical Affiars & Business Strategy
9:50 - 9:57 | Avedro | Reza Zadno, PhD, President & CEO
9:57 - 10:04 | Mynosys Cellular Devices | John Hendrick, President & CEO
10:04 - 10:11 | PowerVision | Barry Cheskin, President, CEO & Co-Founder
10:11 - 10:18 | iStar Medical SA | Michel Vanbrabant, CEO
10:18 - 10:25 | Ivantis | Dave Van Meter, President & CEO
10:25 - 10:32 | EBS Technologies | Karl Schweitzer, CEO
10:32 - 10:39 | TrueVision Systems | Burton Tripathi, PhD, EVP of R&D and Chief Technology Officer
10:39 - 11:00 AM
Morning Networking & Refreshment Break
Sponsored By:
11:00 - 12:10 PM
Company Showcase 3
Co-Moderated By:
Melissa Liew, MD, VP & US Medical Head, Ophthalmology - Novartis
Andrew Stewart, Executive Director - Allergan
11:00 - 11:07 | Aura Biosciences | Elisabet de los pinos, PhD, CEO
11:07 - 11:14 | ONL Therapeutics | John Freshley, President & CEO
11:14 - 11:21 | Aerpio Pharmaceuticals | Joseph Gardner, President & CEO
11:21 - 11:28 | KalVista Pharmaceuticals | Andrew Crockett, CEO
11:28 - 11:35 | Ocunexus Therapeutics | Brian Levy, CEO
11:35 - 11:42 | Allegro Ophthalmics | Vicken Karageozian, MD, President & Chief Medical Officer
11:42 - 11:49 | Iconic Therapeutics | William Greene, MD, CEO
11:49 - 11:56 | Graybug Vision | Jeff Cleland, PhD, President & CEO
11:56 - 12:03 | Ocular Therapeutix | Antony Mattessich, President & CEO
12:03 - 12:10 | Notal Vision | Susan Orr, Chief Medical Officer & VP, Medical Affairs
12:10 - 12:40 PM
Industry Insights into Innovation 2017
Focusing on current trends in innovation and how the morning showcase companies fit in.
Participants:
Robert Dempsey, Group Vice President, Head of Global Ophthalmics Franchise – Shire
Jason Ehrlich, MD, PhD, Global Head, Clinical Ophthalmology Product Development – Genentech
Jane Rady, VP, Business Development, Surgical - Johnson & Johnson Vision
Calvin Roberts, MD, SVP, Chief Medical Officer - Bausch + Lomb
Dirk Sauer, PhD, Global Development Unit Head, Ophthalmology Unit - Novartis Pharma AG
Naveed Shams, MD, PhD, Sr. Corporate Officer, Head, Global R&D and Chief Science Officer - Santen Pharmaceuticals Ltd.
Moderated By:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds
12:40 - 1:30 PM
Networking Lunch
Sponsored By:
1:30 - 1:45 PM
OIS Industry Tribute
Growth Through Metamorphosis: The Story of AMO
1:45 - 2:15 PM
Challenges in Innovation: What Would You Do?
Case studies in real life tough decisions with panel discussion of actual outcomes.
Early stage financing: Randy Alexander, Chairman - ReVision Optics
FDA challenges: Reza Zadno, PhD, President & CEO - Avedro
Commercialization: Bernie Haffey, President - 2020 Management Consulting
Moderated By:
Gilbert H. Kliman, MD, Managing Director - InterWest Partners
2:15 - 2:20 PM
Ophthalmic Innovation 2017 - “A View from the AAO”
David W. Parke II, MD, CEO - American Academy of Ophthalmology (AAO)
2:20 - 2:25 PM
Ophthalmic Innovation 2017 - “A View from the NEI”
Mala Dutta, PhD, Lead, Office of Translational Research - National Eye Institute, NIH
2:25 - 2:55 PM
Blended Careers: Industry and Medicine
Highlighting the migration of KOLs into industry
Participants:
Emmett T. Cunningham Jr., MD, PhD, MPH, Managing Director – Clarus Funds
Ron Kurtz, MD, President & CEO - RxSight
Stephen S. Lane, MD, Chief Medical Officer and Head Global Franchise Clinical Strategy - Alcon/Medical Director - Associated Eye Care
Jai G. Parekh, MD, MBA, Founder - EyeCare Consultants of NJ / VP, Global Medical Affairs Office of CMO, Eyecare & Dermatology -Allergan
Rajesh Rajpal, MD, Chief Medical Officer - Avedro
Steve Schallhorn, MD, Chief Medical Officer - Carl Zeiss Meditec
Jonathan Talamo, MD, Chief Medical Officer, VP Medical & Clinical Affairs - Johnson & Johnson Vision
Moderated By:
Richard Lindstrom, MD, Founder & Attending Surgeon - Minnesota Eye Consultants
2:55 - 3:20 PM
Afternoon Networking & Refreshment Break
Sponsored By:
3:20 - 3:26 PM
Private Funding Trends Presentation
Jonathan Norris, Managing Director - SVB
3:26 - 3:32 PM
A View of the Public Ophthalmology Market
Andrew Gitkin, Head of West Coast Biotechnology Investment Banking - Piper Jaffray
3:32 - 3:35 PM
2017 Update of OIS Index
Michael Lachman, President - EyeQ Research
3:35 - 4:35 PM
Public Device and BioPharma Company Showcase
Moderated By:
Michael Lachman, President - EyeQ Research
3:35 - 3:45 | Aerie Pharmaceuticals | Tom Mitro, COO
3:45 - 3:55 | Alimera Sciences | Dan Myers, CEO
3:55 - 4:05 | Clearside Biomedical | Daniel White, President & CEO
4:05 - 4:15 | Kala Pharmaceuticals | Mark Iwicki, Chairman & CEO
4:15 - 4:25 | Ophthotech Corporation | Glenn Sblendorio, President & CEO
4:25 - 4:35 | Glaukos Corporation | Joe Gilliam, CFO & SVP of Corporate Development
4:35 - 5:05 PM
Masters of the Industry
Industry Executives share how they manage innovation, integration and other challenges facing big companies today.
Participants:
Michael Ball, CEO - Alcon
Tom Frinzi, Worldwide President, Surgical - Johnson & Johnson Vision
Dr. Rafiq Hasan, VP & Global Head of Ophthalmology - Bayer
William J. Link, PhD, Managing Director - Versant Ventures
Ludwin Monz, PhD, President & CEO - Carl Zeiss Meditec AG
Brent Saunders, Chairman, President & CEO - Allergan
Moderated By:
Jim Mazzo, Global President Ophthalmic Devices - Carl Zeiss Meditec
5:05 - 5:10 PM
Closing Remarks
William J. Link, PhD, Managing Director - Versant Ventures
5:10 - 6:10 PM
Networking Reception
Sponsored By:
